Skip to main content

Table 2 Effect of treatment with bosentan on echocardiographic parameters

From: Long-term results of treatment with bosentan in adult Eisenmenger’s syndrome patients with Down’s syndrome related to congenital heart disease

Parameter

Baseline

Final follow-up

P valuea

RVSP from TR (mmHg) (n = 4)

94.0 ± 13.4

85.5 ± 7.6

0.3750

Peak velocity of PR (m/s) (n = 2)

4.00 ± 0.14

4.05 ± 0.07

1.0000

AcT (m/s)

62.9 ± 11.6

83.0 ± 9.6

0.0156

AcT/ET

0.24 ± 0.04

0.30 ± 0.02

0.0156

  1. RVSP: right ventricular systolic pressure; TR: tricuspid regurgitation; PR: pulmonary regurgitation; AcT: acceleration time; AcT/ET: acceleration/ejection time ratio; aWilcoxon signed-rank test.
Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us